Rising Precious Jewelry Purchase To Drive Luxury Jewelry Market Growth

Luxury Jewelry Market
Luxury Jewelry Market

Luxury Jewelry Market by Product Type (Necklaces, Ring, Earrings, Bracelets, Others), by Application (Men, Women, Children), by Distribution Channel (Online, Offline) and by Region (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

The global Luxury Jewelry Market is estimated to be valued at US$ 60.9 Billion in 2023 and is expected to exhibit a CAGR of 7.85 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Luxury Jewelry is very expensive, lavish accessory that provides a level of exclusiveness and standard. Its look is enhanced by the extensive substances utilized to design it, from 18 carat gold to attractive eye-clean gems and clash-free stones of diamond. Apart from the limitations that have been occurred due to the COVID-19 epidemic, e-commerce is still an important method for luxury jewelers to spread among new users and enhance their sales. This can be made by utilizing a vast range of plans, from social media to digital-to-store enticements.

Competitive Landscape:

Key players involved in the growth of global Luxury Jewelry Market are Guccio Gucci S.p.A., Louis Vuitton SE., Chopard International SA, The Swatch Group Ltd., Pandora Jewelry, LLC, Signet Jewelers Limited, Richemont, MIKIMOTO, Tiffany & Co. and GRAFF.

Market Key Drivers:

The rise in female self-purchase of precious jewelry is expected to drive the growth of global Luxury Jewelry for Market. For instance, as per PGI's 2020 evaluation 77% of female residents in India and China and 59.0% of female users in America, bought non-bridal jewelry for self in 2020.

Rise in unisex pieces in the market is projected to propel the growth of global Luxury Jewelry for Market. For instance, Gucci's jewelry collection was designed at all genders and Bugari's B.Zero 1 Rock designs are modern, stylish, and unisex.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of global Luxury Jewelry Market due to the disruption in supply chains. It created a mass interruption for buyers and also the sellers. Manufacturing and production units have been closed globally which has halted the production, sale, and selling of the product. This has also provided a chance for the organizations to look after their supply chain interactions and business models for the future. All these factors has impeded the market growth.

Key Takeaways:

The global Luxury Jewelry for Market is anticipated to exhibit a CAGR of 7.85 % during the forecast period owing to the rise in offline purchases. For instance, as per a survey in 2021, even though users browsed or chose products digitally, only 15-20% of them purchased online jewelry, and the remainder chose to buy these items from offline stores.

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in the global Luxury Jewelry Market due to mergers and acquisitions, product expansions and growing purchases of yellow gold, white gold and diamond. For instance, The luxury brands Graff and MIKIMOTO have announced the launch of a flagship stores in Hong Kong in 2020 and New York in 2021, consecutively.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more